BlockBeats news, on June 18, according to market news, the clinical-stage ophthalmic biopharmaceutical company Eyenovia announced an investment of 50 million dollars to launch the Hyperliquid (HYPE) treasury reserve strategy.
Biopharmaceutical company Eyenovia launches HYPE treasury reserve strategy, investing 50 million dollars
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
HYPEUSDT
Perp
40.86
-8.09%
Explore the latest crypto news
⚡️ Be a part of the latests discussions in crypto
💬 Interact with your favorite creators
👍 Enjoy content that interests you
Email / Phone number
Relevant Creator
@BlockBeats
